Rare diseases
Investigational molecules
Locations
Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence
FranceStudy of aneratrigine mesilate (iN1011-N17-02) to find the best dose for treating pain in adults with post-herpetic neuralgia
BulgariaComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
BulgariaStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
BelgiumStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
AustriaStudy of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes
CzechiaStudy of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis
BelgiumEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
BulgariaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
BelgiumStudy on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus
BulgariaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
BelgiumStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents
EstoniaTell us about your condition – we search every trial in Europe and connect you with the right site.
